# Director, Medical Writing at Lyell Immunopharma

- Company: Lyell Immunopharma
- What the company does: Lyell is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Backed by 8VC.
- Company website: https://lyell.com
- Type: Startups
- Level: Principal and up
- Location: USA
- Work setup: On-site
- Pay: $220K to $240K base salary per year (USD)
- Posted: 2026-09-03
- Apply by: 2026-10-19
- Apply: https://job-boards.greenhouse.io/lyellimmunopharma/jobs/7986060003?utm_source=1752vc&utm_medium=careers
- Page: https://www.1752.vc/careers/jobs/lyell-immunopharma-director-medical-writing/

## About the role

Reporting to the VP of Regulatory Affairs, this individual will partner with Regulatory and Clinical Development providing responsive, available, and action-focused support, able to turn a design discussion into draft text quickly. Recurring deliverables are protocols, protocol amendments, Investigator’s Brochures, and clinical study reports, which move on clinical timelines and cannot slip. In parallel, you will author Module 2 clinical summary content as the submission takes shape. Found on 1752vc Careers, the job board for startup and VC roles.

## What they're looking for

- Health authority briefing documents. Type B/C/D and pre-BLA packages, information request responses, and advisory committee materials
- 10+ years of medical writing in biotech or pharma, with substantial time in clinical regulatory writing
- Lead-author depth on protocols, amendments, and Investigator’s Brochures — not coordinator or reviewer
- Working knowledge of ICH E3, E6(R3), E2, and M4E, CTD/eCTD structure, and applicable 21 CFR requirements
- Proven track record managing outsourced writing vendors: scoping, budget, and quality oversight

Tags: Regulatory Affairs

Source: 1752vc Careers, https://www.1752.vc/careers/jobs/lyell-immunopharma-director-medical-writing/